CD274 and neoplasm: With multiple tumor entities showing PD-L1 expression, including UCB, and due to the disproportionately long-lasting efficacy in a subgroup of patients receiving ICI, predictive biomarkers for patients with UCB have been discussed [18,21,22,23].